Terms: = Lung cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Prognosis
37 results:
1. Circulating miR-10b, soluble urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 as predictors of non-small cell lung cancer progression and treatment response.
Setiawan L; Setiabudy R; Kresno SB; Sutandyo N; Syahruddin E; Jovianti F; Nadliroh S; Mubarika S; Setiabudy R; Siregar NC
Cancer Biomark; 2024; 39(2):137-153. PubMed ID: 38073374
[TBL] [Abstract] [Full Text] [Related]
2. serpine1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer.
Ou J; Liao Q; Du Y; Xi W; Meng Q; Li K; Cai Q; Pang CLK
Free Radic Biol Med; 2023 Nov; 209(Pt 1):96-107. PubMed ID: 37838303
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a cancer-associated fibroblast classifier for predicting prognosis and therapeutic response in lung squamous cell carcinoma.
Lai X; Fu G; Du H; Xie Z; Lin S; Li Q; Lin K
Medicine (Baltimore); 2023 Sep; 102(38):e35005. PubMed ID: 37746966
[TBL] [Abstract] [Full Text] [Related]
4. Unraveling the potential of senescence-related genes in guiding clinical therapy of lung adenocarcinoma patients.
Liu C; Wei X
Funct Integr Genomics; 2023 May; 23(2):188. PubMed ID: 37246190
[TBL] [Abstract] [Full Text] [Related]
5. Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma.
Song C; Lu Z; Lai K; Li D; Hao B; Xu C; Pan S; Li N; Geng Q
Sci Rep; 2022 Jun; 12(1):10110. PubMed ID: 35710585
[TBL] [Abstract] [Full Text] [Related]
6. Identification of Novel Biomarkers Related to lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis.
Wang H; Huang L; Chen L; Ji J; Zheng Y; Wang Z
Comput Math Methods Med; 2021; 2021():9059116. PubMed ID: 34659450
[TBL] [Abstract] [Full Text] [Related]
7. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
[TBL] [Abstract] [Full Text] [Related]
8. Crosstalk between YAP and TGFβ regulates serpine1 expression in mesenchymal lung cancer cells.
Kong HJ; Kwon EJ; Kwon OS; Lee H; Choi JY; Kim YJ; Kim W; Cha HJ
Int J Oncol; 2021 Jan; 58(1):111-121. PubMed ID: 33367928
[TBL] [Abstract] [Full Text] [Related]
9. Lupeol suppresses plasminogen activator inhibitor-1-mediated macrophage recruitment and attenuates M2 macrophage polarization.
Park HJ; Chi GY; Choi YH; Park SH
Biochem Biophys Res Commun; 2020 Jul; 527(4):889-895. PubMed ID: 32430175
[TBL] [Abstract] [Full Text] [Related]
10. Immune Checkpoint Inhibitor-Associated Primary Adrenal Insufficiency: WHO VigiBase Report Analysis.
Grouthier V; Lebrun-Vignes B; Moey M; Johnson DB; Moslehi JJ; Salem JE; Bachelot A
Oncologist; 2020 Aug; 25(8):696-701. PubMed ID: 32390168
[TBL] [Abstract] [Full Text] [Related]
11. The urokinase-type plasminogen activator and inhibitors in resectable lung adenocarcinoma.
Zhu C; Jiang L; Xu J; Ren A; Ju F; Shu Y
Pathol Res Pract; 2020 Apr; 216(4):152885. PubMed ID: 32113794
[TBL] [Abstract] [Full Text] [Related]
12. Plasminogen Activator Inhibitor 1 (pai1) Promotes Actin Cytoskeleton Reorganization and Glycolytic Metabolism in Triple-Negative Breast cancer.
Humphries BA; Buschhaus JM; Chen YC; Haley HR; Qyli T; Chiang B; Shen N; Rajendran S; Cutter A; Cheng YH; Chen YT; Cong J; Spinosa PC; Yoon E; Luker KE; Luker GD
Mol Cancer Res; 2019 May; 17(5):1142-1154. PubMed ID: 30718260
[TBL] [Abstract] [Full Text] [Related]
13. Correlation of Serum Levels of Urokinase Activation Plasminogen (uPA) and Its Inhibitor (pai-1) with Hormonal and HER-2 Status in the Early Invasive Breast cancer.
Pusina S
Med Arch; 2018 Nov; 72(5):335-340. PubMed ID: 30524164
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract] [Full Text] [Related]
15. pai-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract] [Full Text] [Related]
16. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W
Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146
[TBL] [Abstract] [Full Text] [Related]
17. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
Rangel R; Lee SC; Hon-Kim Ban K; Guzman-Rojas L; Mann MB; Newberg JY; Kodama T; McNoe LA; Selvanesan L; Ward JM; Rust AG; Chin KY; Black MA; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7749-E7758. PubMed ID: 27849608
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of pai-1 Limits Tumor Angiogenesis Regardless of Angiogenic Stimuli in Malignant Pleural Mesothelioma.
Takayama Y; Hattori N; Hamada H; Masuda T; Omori K; Akita S; Iwamoto H; Fujitaka K; Kohno N
Cancer Res; 2016 Jun; 76(11):3285-94. PubMed ID: 27197170
[TBL] [Abstract] [Full Text] [Related]
19. Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell lung cancer.
Su CY; Liu YP; Yang CJ; Lin YF; Chiou J; Chi LH; Lee JJ; Wu AT; Lu PJ; Huang MS; Hsiao M
PLoS One; 2015; 10(7):e0133411. PubMed ID: 26230665
[TBL] [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor variants pai-1 A15T and pai-2 S413C influence lung cancer prognosis.
Di Bernardo MC; Matakidou A; Eisen T; Houlston RS;
Lung Cancer; 2009 Aug; 65(2):237-41. PubMed ID: 19117638
[TBL] [Abstract] [Full Text] [Related]
[Next]
